Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06142006 · ClinicalTrials.gov registry record
The Diabetes Staging System in Patient Aligned Care Teams
A clinical trial of Type 2 Diabetes and Diabetes Mellitus, sponsored by Durham VA Medical Center.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06142006: Recruiting study of Type 2 Diabetes and Diabetes Mellitus, sponsored by Durham VA Medical Center.
NCT06142006 is a study of Type 2 Diabetes and Diabetes Mellitus that is actively recruiting participants, run by Durham VA Medical Center. The registered enrollment target is 120 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06142006, a study of Type 2 Diabetes and Diabetes Mellitus, is actively recruiting participants, sponsored by Durham VA Medical Center.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the feasibility/acceptability of the Diabetes Staging System (DSS) in Patient Aligned Care Teams (PACT) teams and its ability to increase sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like-1 peptide (GLP-1) use in Veteran patients with type 2 diabetes and cardiovascular disease and/or chronic kidney disease.
Conditions Studied
Interventions
- OTHER Diabetes Staging System (DSS) use among Primary Care Teams
Study Locations (1)
North Carolina
- Greenville VA Health Care Center, 401 Moye Blvd - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2025-09-01 |
What NCT06142006 shows while recruiting
NCT06142006 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Staging System (DSS) use among Primary Care Teams is the first listed.
NCT06142006 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06142006 about?
NCT06142006 is a clinical study titled "The Diabetes Staging System in Patient Aligned Care Teams". The purpose of this study is to examine the feasibility/acceptability of the Diabetes Staging System (DSS) in Patient Aligned Care Teams (PACT) teams and its ability to increase sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like-1 peptide (GLP-1) use in Veteran patients with type 2 ...
What is the current status of trial NCT06142006?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2023-09-01. Estimated completion is 2025-09-01.
What conditions does trial NCT06142006 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Diabetes Mellitus.
What interventions are being tested in trial NCT06142006?
The interventions under investigation include: Diabetes Staging System (DSS) use among Primary Care Teams (OTHER).
Who is sponsoring clinical trial NCT06142006?
This trial is sponsored by Durham VA Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06142006 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06142006's enrollment target sits among peer trials
120 133rd of 327 higher than 193 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
Mechanism of SGLT2 Inhibition in the Kidney
RECRUITING · Phase 4
-
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI